Live Feed

4 - OneMedNet Corp (0001849380) (Issuer)

8-K - Dyne Therapeutics, Inc. (0001818794) (Filer)

Diana Shares Valued at $2.54 Per Share Based on Diana's Volume-Weighted Average Price for the 30 Days Ended on June 16, 2026 Revised Offer Reflects a 53% Premium to Genco's Undisturbed Share Price and a 6% Premium to NAV at Cyclically High Drybulk Asset Values at or Near 15-Year Highs Provides Genco Shareholders Immediate Cash Certainty Plus Opportunity for Equity Participation in the Combined Company Diana Requests That Genco Delay the Annual Meeting Currently Scheduled for June 18 to Allow the Board and Shareholders Time to Properly Evaluate the Increased Offer CEO Semiramis Paliou and Other Diana Executives Intend to Maintain Their Existing Ownership Percentages in Diana Through Open

8-K - JABIL INC (0000898293) (Filer)

NEW ORLEANS, June 17, 2026 (GLOBE NEWSWIRE) -- Rental applicants with unusually high numbers of recent credit inquiries pose the greatest fraud risk for property managers, according to TransUnion (NYSE:TRU) research released today at Apartmentalize 2026. Applicants with 15 or more credit inquiries in the seven days prior to applying for a lease showed the highest rate of charge-offs within one year, at 32%, compared with nearly 9% for the overall sample. The research identified the top 15 fraud indicators based on their ability to help predict a negative outcome within 12 months after a renter applied for a lease. Another leading indicator was having eight or more credit inquiries within

Ness Ziona, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ:NXTS) ("Nexentis" or the "Company"), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, today announced that its wholly owned subsidiary, MitoCareX Bio Ltd. ("MitoCareX"), today reported that it has completed a broad structural analysis of human SLC (Solute Carrier) transport proteins as part of its ongoing efforts to expand and refine its small-molecule discovery capabilities. This work builds on MITOLINE®, MitoCareX's proprietary sequence analysis and alignment algorithm, which to date has been used to prepare mitochondrial SLC25 carri

8-K - N-able, Inc. (0001834488) (Filer)

Boca Raton, Florida--(Newsfile Corp. - June 17, 2026) - Atlas Lithium Corp. (NASDAQ:ATLX) ("Atlas Lithium" or the "Company") today announced that Chairman and CEO Marc Fogassa will deliver the Strategic Keynote Presentation opening the first session, "Lithium in Brazil: Building a Competitive Industry," at the 3rd Brazil Lithium & Critical Minerals Summit 2026, to be held June 17-18 in Belo Horizonte, Minas Gerais, Brazil. The summit is recognized as the premier business and investment platform for Brazil's growing critical minerals sector.Fogassa's keynote will highlight how Brazil is building a globally competitive critical minerals supply chain, supported by a stable jurisdiction, establi

8-K/A - Soluna Holdings, Inc (0000064463) (Filer)

8-K - GRAHAM CORP (0000716314) (Filer)

6-K - Wellchange Holdings Co Ltd (0001990251) (Filer)

90% of patients in the study presented with metastatic (Stage IV) disease at diagnosis 6-month overall survival rate was 86%; follow-up continues and survival data continue to mature Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced positive updated safety and efficacy results from the RAMP 205 Phase 1b/2a Recommended Phase 2 Dose (RP2D) cohort of 29 patients evaluating avutometinib plus defactinib in combination with gemcitabine and nab-paclitaxel in first-line metastatic pancreatic ductal adenocarcinoma (PDAC). KRAS is mutated in more than 90% of pancreatic cancers, mak

Raises Fiscal 2026 Outlook Today, Jabil Inc. (NYSE:JBL), reported preliminary, unaudited financial results for its third quarter of fiscal year 2026. Third Quarter of Fiscal Year 2026 Highlights: Net revenue: $8.8 billion U.S. GAAP operating income: $445 million U.S. GAAP diluted earnings per share: $2.59 Core operating income (Non-GAAP): $504 million Core diluted earnings per share (Non-GAAP): $3.16 "Jabil delivered a very strong third quarter, with results ahead of our expectations across revenue, core operating margin, core EPS, and free cash flow," said CEO Mike Dastoor. "AI infrastructure demand remains extremely strong, and our full-year AI-related revenue outloo

Entrepreneur brings two decades of experience building high-growth brokerages and agent-centric businesses The Real Brokerage Inc. (NASDAQ:REAX), a real estate technology platform focused on innovation and agent culture, today announced that entrepreneur and JPAR Real Estate founder JP Piccinini will be working with Real as a Growth Leader. In this role, he will work closely with Chief Growth Officer Jason Cassity to support agents, teams and brokerage leaders across the Real network. Over the course of his career, Piccinini has served as an agent, brokerage owner, franchisee and franchisor, giving him a broad perspective on the real estate industry at every stage of business developmen

FOREST PARK, Ohio, June 17, 2026 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (NASDAQ:HLMN) (the "Company", "Hillman Group", or "Hillman"), a leading provider of hardware products and merchandising solutions, and Hillwood Investment Properties ("Hillwood"), held a groundbreaking ceremony for a new multipurpose facility at the former Forest Fair Mall site in Forest Park, Ohio. The project marks a major milestone in the transformation of the long-vacant property into a modern multipurpose facility and brought together leaders from local government, economic development organizations, and redevelopment partners to commemorate the occasion. Hillman will lease and fully occupy the space as its

RENO, Nev., June 17, 2026 (GLOBE NEWSWIRE) -- USBC, Inc. (NYSE:USBC) ("USBC" or the "Company"), a publicly traded technology company that seeks to enable the transformation of traditional U.S. bank dollars into secure, compliant tokenized deposits, today announced that it submitted a comment letter to the Federal Deposit Insurance Corporation ("FDIC") to express its support for how tokenized bank deposits will be treated under federal banking rules in response to the FDIC's request for public feedback on the proposed rule to implement parts of the GENIUS Act. Read USBC's full letter to the FDIC here. "We believe the FDIC proposal represents an important and responsible step forward to fo

NEW HAVEN, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (NASDAQ:TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced that senior management will attend several upcoming events in June and July.   BIO International Convention June 22-25, 2026, San Diego, CaliforniaTrevi Representatives: Jennifer Good, President and CEO, and Farrell Simon, Pharm.D., CCO   Leerink Partners Therapeutics Forum 2026July 14-15, 2026, Bosto

- Up to $125 million in additional borrowing capacity provides further strategic flexibility - - $50 million of additional capacity funded at amendment closing - WALTHAM, Mass., June 17, 2026 (GLOBE NEWSWIRE) --  Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has entered into an amendment to its non-dilutive senior secured term loan facility with Hercules Capital, Inc. (NYSE:HTGC), a leader in customized debt financing for companies in the life sciences and technology-related markets. The transaction further strengthens the company's balan

HAMBURG, Germany and MUNICH, June 17, 2026 (GLOBE NEWSWIRE) -- XCHG Limited ("XCharge" or the "Company") (NASDAQ:XCH), an integrated EV charging and energy solutions company, is presenting the new generation of its C7 DC fast-charging station at Power2Drive Europe in Munich. The advanced charging station offers up to 480 kW of charging power. With the new C7, XCharge is addressing the growing demand in Europe for high-performance, operator-friendly, and scalable charging infrastructure. The updated product builds on proven field experience from deployments with leading charge point operators. This market relevance is also reflected in the collaboration with EnBW: The operator of Germany's

Daniel J. Thoren to Retire and Step Down as Executive Chairman, Continue as Strategic Advisor Through June 2027 Graham Corporation (NYSE:GHM), a global leader in the design and manufacture of mission critical fluid, power, heat transfer, vacuum, and advanced mixing technologies for the defense, space, energy, and process industries, today announced that Jonathan W. Painter has been appointed Chairman of the Board of Directors, effective June 15, 2026. The appointment follows the decision by Daniel J. Thoren to retire and step down from his role as Executive Chairman and as a Director as part of the executive transition plan announced in February last year. Mr. Thoren will continue to serv